Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 10, keine Gesamtzahl für „consistent“
Suchtreffer
Begriffe & Kennungen
Rybelsus · 4.8 · Immunogenicity Consistent with the potential immunogenic properties of medicinal products containing proteins
Eintrag öffnenRybelsus · 4.8 · Immunogenicity Consistent with the potential immunogenic properties of medicinal products containing proteins
Eintrag öffnenShingrix · 4.8 · In clinical studies in IC adults ≥ 18 years of age (1 587 subjects) the safety profile is consistent with the
Eintrag öffnenShingrix · 4.8 · In clinical studies in IC adults ≥ 18 years of age (1 587 subjects) the safety profile is consistent with the
Eintrag öffnenSignifor · 4.8 · The safety profile of pasireotide intramuscular use is consistent with the somatostatin analogue class, except
Eintrag öffnenSildenafil Actavis · 4.3 · Consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cGMP) pathway (see secti
Eintrag öffnenSildenafil Actavis · 4.5 · 6 In vivo studies Consistent with its known effects on the nitric oxide/cGMP pathway (see section 5.1), silden
Eintrag öffnenSildenafil Teva · 4.3 · Consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cGMP) pathway (see secti
Eintrag öffnenSildenafil Teva · 4.5 · In vivo studies: Consistent with its known effects on the nitric oxide/cGMP pathway (see section 5.1), sildena
Eintrag öffnenSildenafil ratiopharm · 4.3 · Consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cGMP) pathway (see secti
Eintrag öffnenSildenafil ratiopharm · 4.5 · In vivo studies Consistent with its known effects on the nitric oxide/cGMP pathway (see section 5.1), sildenaf
Eintrag öffnenSkyclarys · 4.8 · The safety profile observed in the open-label extension study was consistent with the safety profile observed
Eintrag öffnenSkyrizi · 4.8 · Overall, the safety profile observed in patients with Crohn’s disease treated with risankizumab was consistent
Eintrag öffnenSkyrizi · 4.8 · Overall, the safety profile observed in patients with Crohn’s disease treated with risankizumab was consistent
Eintrag öffnenSkyrizi · 4.8 · Overall, the safety profile observed in patients with Crohn’s disease treated with risankizumab was consistent
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Reactogenicity was consistent with the known profile of Spikevax (original). There were no unexpected safety f
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Reactogenicity was consistent with the known profile of Spikevax (original). There were no unexpected safety f
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Reactogenicity was consistent with the known profile of Spikevax (original). There were no unexpected safety f
Eintrag öffnenSprycel · 4.8 · In the paediatric ALL studies, the rates of laboratory abnormalities were consistent with the known profile fo
Eintrag öffnenSprycel · 4.8 · In the paediatric ALL studies, the rates of laboratory abnormalities were consistent with the known profile fo
Eintrag öffnen